RPID — Rapid Micro Biosystems Income Statement
0.000.00%
Last trade - 00:00- $136.17m
- $105.12m
- $28.05m
- 15
- 23
- 41
- 15
Annual income statement for Rapid Micro Biosystems, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 16.1 | 23.2 | 17.1 | 22.5 | 28.1 |
| Cost of Revenue | |||||
| Gross Profit | -8.07 | -7.74 | -8.54 | -5.49 | -0.109 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 49.5 | 73.6 | 80.4 | 79.1 | 78 |
| Operating Profit | -33.5 | -50.3 | -63.2 | -56.6 | -49.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -36.9 | -73.4 | -61.4 | -52.4 | -46.9 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -37.1 | -73.5 | -60.8 | -52.5 | -46.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -37.1 | -73.5 | -60.8 | -52.5 | -46.9 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -45.2 | -78 | -60.8 | -52.5 | -46.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -1.08 | -1.83 | -1.43 | -1.22 | -1.08 |
| Dividends per Share |